Piramal Pharma (NSE:PPLPHARMA) Pre-Tax Income : ₹1,793 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Piramal Pharma's pretax income for the three months ended in Mar. 2024 was ₹2,275 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,793 Mil. Piramal Pharma's pretax margin was 8.91%.

During the past 4 years, Piramal Pharma's highest Pretax Margin was 23.37%. The lowest was -1.70%. And the median was 4.83%.

Piramal Pharma Pre-Tax Income Historical Data

The historical data trend for Piramal Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Pre-Tax Income Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Pre-Tax Income

6,867.80

4,849.80

-1,201.50

1,792.90

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial							948.90	-1,071.10	395.60	193.60	2,274.80

Competitive Comparison of Piramal Pharma's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piramal Pharma's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's Pre-Tax Income falls into.

Piramal Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Piramal Pharma's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	4556.9	+	0	+	-4484.9	+	0	+	1720.9
	=	1,793

Piramal Pharma's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	3338	+	0	+	-1142.2	+	0	+	79
	=	2,275

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,793 Mil.

Piramal Pharma (NSE:PPLPHARMA) Pre-Tax Income Explanation

Piramal Pharma's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	2274.8	/	25523.6
	=	8.91%

During the past 4 years, Piramal Pharma's highest Pretax Margin was 23.37%. The lowest was -1.70%. And the median was 4.83%.

Piramal Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Pre-Tax Income

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines